Eradication of Methicillin-Resistant Staphylococcus aureus Carriage: A Systematic Review
HSM Ammerlaan, JAJW Kluytmans… - Clinical Infectious …, 2009 - academic.oup.com
A systematic review was performed to determine the effectiveness of different approaches
for eradicating methicillin-resistant Staphylococcus aureus carriage. Twenty-three clinical …
for eradicating methicillin-resistant Staphylococcus aureus carriage. Twenty-three clinical …
Convalescent plasma for COVID-19. A randomized clinical trial
…, GR van Pottelberge, IN Vlasveld, HSM Ammerlaan… - MEDRxiv, 2020 - medrxiv.org
Structured abstract for full paper Background After recovery from COVID-19, most patients
have anti-SARS-CoV-2 neutralizing antibodies. Their convalescent plasma could be an …
have anti-SARS-CoV-2 neutralizing antibodies. Their convalescent plasma could be an …
Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
…, IN Vlasveld, HSM Ammerlaan… - Nature …, 2021 - nature.com
In a randomized clinical trial of 86 hospitalized COVID-19 patients comparing standard care
to treatment with 300mL convalescent plasma containing high titers of neutralizing SARS-…
to treatment with 300mL convalescent plasma containing high titers of neutralizing SARS-…
Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient …
WC Rottier, HSM Ammerlaan… - Journal of Antimicrobial …, 2012 - academic.oup.com
Background and objectives Bacteraemia caused by Enterobacteriaceae (EB) producing
extended-spectrum β-lactamase (ESBL+) has been associated with higher mortality compared …
extended-spectrum β-lactamase (ESBL+) has been associated with higher mortality compared …
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study
…, LBS Gelinck, EF Schippers, HSM Ammerlaan… - PLoS …, 2022 - journals.plos.org
Background Vaccines can be less immunogenic in people living with HIV (PLWH), but for
SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the …
SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the …
Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline
HSM Ammerlaan, JAJW Kluytmans… - Journal of …, 2011 - academic.oup.com
Background We evaluated the effectiveness of eradication of methicillin-resistant Staphylococcus
aureus (MRSA) carriage in the Netherlands after the introduction of a guideline in 2006…
aureus (MRSA) carriage in the Netherlands after the introduction of a guideline in 2006…
Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis
…, PD van der Linden, HSM Ammerlaan… - Clinical infectious …, 2015 - academic.oup.com
Background. To prevent inappropriate empiric antibiotic treatment in patients with bacteremia
caused by third-generation cephalosporin (3GC)–resistant Enterobacteriaceae (3GC-R EB)…
caused by third-generation cephalosporin (3GC)–resistant Enterobacteriaceae (3GC-R EB)…
[HTML][HTML] Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled …
…, A Aardenburg-van Huisstede, HSM Ammerlaan… - Clinical Microbiology …, 2023 - Elsevier
Objectives To test whether Bacillus Calmette-Guérin (BCG) vaccination would reduce the
incidence of COVID-19 and other respiratory tract infections (RTIs) in older adults with one or …
incidence of COVID-19 and other respiratory tract infections (RTIs) in older adults with one or …
Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure
HSM Ammerlaan, JAJW Kluytmans… - Journal of …, 2011 - academic.oup.com
Background Using data from an observational study in which the effectiveness of a guideline
for eradication of methicillin-resistant Staphylococcus aureus (MRSA) carriage was …
for eradication of methicillin-resistant Staphylococcus aureus (MRSA) carriage was …
Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial
…, R Soetekouw, HSM Ammerlaan… - The lancet …, 2019 - thelancet.com
Background Direct-acting antivirals effectively treat chronic hepatitis C virus (HCV) infection
but there is a paucity of data on their efficacy for acute HCV, when immediate treatment …
but there is a paucity of data on their efficacy for acute HCV, when immediate treatment …
